Synthesis and Anti-HIV Activity of d- and l-Thietanose Nucleosides

Journal of Medicinal Chemistry
2006.0

Abstract

Various D- and L-thietanose nucleosides were synthesized from D- and L-xylose. The four-membered thietane ring was efficiently synthesized by the cyclization of 1-thioacetyl-3-mesylate (4/38) under basic conditions. Condensation with various heterocyclic bases was conducted via Pummerer-type rearrangement to afford various nucleoside derivatives. Among the synthesized nucleosides, D-uridine (23), D-cytidine (24), D-5-fluorocytidine (25), and L-cytidine (52) analogues showed moderate anti-HIV activity, with EC50 = 6.9, 1.3, 5.8, and 14.1 microM, respectively. However, these four nucleoside analogues are cytotoxic in peripheral blood mononuclear and CEM cells. The other nucleosides are neither active nor cytotoxic. Interestingly, the oxetanocin A analogue 33 was not active. Comparison of the minimized reverse transcriptases (RTs) complexed with the corresponding triphosphates of the cytidine analogue 24 and the adenosine analogue 33 by molecular modeling studies showed that there is no difference in the binding mode of the triphosphate of the cytidine analogue 24 to the active site of HIV-1 RT from that of the triphosphate of the adenosine analogue 33. Modeling studies on the initial monophosphorylation step by deoxycytidine kinase showed that the catalytic efficiency of phosphorylation through a nucleophilic attack of the 4'-hydroxyl group of thietanose on the gamma-phosphate of ATP is diminished in the case of L-cytidine analogue (52) due to the increased distance between the 4'-hydroxyl group and the gamma-phosphate.

Knowledge Graph

Similar Paper

Synthesis and Anti-HIV Activity of <scp>d</scp>- and <scp>l</scp>-Thietanose Nucleosides
Journal of Medicinal Chemistry 2006.0
Synthesis, Anti-HIV Activity, and Molecular Mechanism of Drug Resistance of <scp>l</scp>-2‘,3‘-Didehydro-2‘,3‘-dideoxy-2‘-fluoro-4‘-thionucleosides
Journal of Medicinal Chemistry 2003.0
Stereoselective Synthesis and Antiviral Activity of <scp>d</scp>-2‘,3‘-Didehydro-2‘,3‘-dideoxy-2‘-fluoro-4‘-thionucleosides
Journal of Medicinal Chemistry 2002.0
Synthesis of 5-thiodidehydropyranylcytosine derivatives as potential anti-HIV agents
Bioorganic &amp; Medicinal Chemistry Letters 2011.0
Synthesis, Structure−Activity Relationships, and Mechanism of Drug Resistance of <scp>d</scp>- and <scp>l</scp>-β-3‘-Fluoro-2‘,3‘-unsaturated-4‘-thionucleosides as Anti-HIV Agents
Journal of Medicinal Chemistry 2004.0
Synthesis, anti-human immunodeficiency virus, and anti-hepatitis B virus activity of pyrimidine oxathiolane nucleosides
Bioorganic &amp; Medicinal Chemistry Letters 1993.0
Synthesis of enantiomerically pure d- and l-bicyclo[3.1.0]hexenyl carbanucleosides and their antiviral evaluation
Bioorganic &amp; Medicinal Chemistry 2011.0
Synthesis and anti-HIV activity of 4'-thio-2',3'-dideoxynucleosides
Journal of Medicinal Chemistry 1992.0
Synthesis and in vitro evaluation of some modified 4-thiopyrimidine nucleosides for prevention or reversal of AIDS - associated neurological disorders
Journal of Medicinal Chemistry 1990.0
Asymmetric synthesis and biological evaluation of .beta.-L-(2R,5S)- and .alpha.-L-(2R,5R)-1,3-oxathiolane-pyrimidine and -purine nucleosides as potential anti-HIV agents
Journal of Medicinal Chemistry 1993.0